Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Immunomedics allowed patent for therapeutic vaccines

Feb. 10, 2000

FluMist provides unexpected protection against flu strain not covered by vaccine in children

Feb. 9, 2000

North American Vaccine reports Hib vaccine results to FDA advisory panel

Feb. 8, 2000

Development of Chlamydia vaccine subject of Argonex/Wyeth-Lederle collaboration

Feb. 7, 2000

Immunomodulating CB2 receptor ligands in development at Sanofi-Synthelabo

Feb. 7, 2000

Cel-Sci receives MIPS award to support TB vaccine development

Feb. 2, 2000

Nexell acquires access to Diaclone antibodies for use in cell therapy

Feb. 2, 2000

Application of Ariad's Dimerizer Drug technology covered by two U.S. patents

Jan. 31, 2000

Intranasal IL-12 is a potent adjuvant for enhancing antiviral immunity

Jan. 28, 2000

PADRE technology shows promise as universal vaccine immune stimulant

Jan. 26, 2000

Popular Stories

Today's news in brief
BioWorld
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
SERCA inhibitor from Sumitomo shows promise for MSA-C treatment
BioWorld Science
At the ongoing International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders (AD/PD 2026) in Copenhagen, Sumitomo Pharma Co....